In C. elegans, there are many different molecular routes to FoxO activation, and activating more than one at the same time can produce spectacular (six-fold or greater) lifespan increases. No one knows whether anything like this will ever be possible in humans, but we, too, are likely to have many different FoxO-activating drug targets in our bodies.